Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 12—December 2008

Antibodies against Rickettsia spp. in Hunters, Germany

On This Page
Article Metrics
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: A number of emerging Rickettsia species have been recently described (1). One of these, R. helvetica, was first isolated in Switzerland in 1979 and was implicated in perimyocarditis and nonspecific febrile disease in humans (25). PCR showed its prevalence in 1,187 Ixodes ricinus ticks in southern Germany to be 8.9% (6). This finding raises the question whether autochthonous transmission of rickettsiae to humans may occur in Germany. To help answer this question, we conducted a cross-sectional study of the presence of antibodies against Rickettsia spp. in a population in Germany presumably exposed to ticks.

On February 4–5, 2006, we used convenience sampling to enroll 286 hunters at a national hunting fair in Dortmund, Germany. All study participants gave written, informed consent. The Ethics Committee of the Charité approved the study.

Every participant completed a standardized questionnaire. Serum samples were collected from all hunters and analyzed by immunofluorescence assay for 9 Rickettsia species (R. conorii, R. slovaca, R. helvetica, R. massiliae, R. mongolitimonae, R. israelensis, R. aeschlimannii, R. felis, and R. typhi) as described previously (7). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using SPSS software version 14 (SPSS, Inc., Chicago, IL, USA). We considered p<0.05 to be significant.

Of the 286 hunters, 252 (88.1%) were male; median age was 46 years (range 17–79 years). Positive antibody titers (immunoglobulin [Ig] G, IgM, or both) against any Rickettsia spp. were found for 26 (9.1%) hunters (95% CI 6.2–13.0). Antibodies against different Rickettsia spp. were found for 18 hunters; species-specific antibodies against R. helvetica were found for 2 hunters and against R. aeschlimannii for 6 (Table). Seropositive and seronegative hunters did not differ significantly with respect to sex, age, and total years of hunting. Neither hunting nor traveling in a foreign country within the past 5 years was significantly associated with seropositivity. Neither of the 2 hunters with R. helvetica–specific antibody titers had traveled outside Germany in the 5 years before the study, but 3 of the 6 hunters with specific titers against R. aeschlimannii had traveled and hunted in countries with unknown endemicity for R. aeschlimannii (Russia, Romania, Namibia). A total of 212 (74.1%) hunters had received at least 1 tick bite in the year before the study; median was 4 tick bites/year. Living in the southern parts of Germany (below 50°N) was significantly related to seropositivity (OR 4.1, 95% CI 1.3–12.3, p = 0.02). Although the 26 persons with positive serologic results for Rickettsia spp. reported arthralgia with higher frequency than did seronegative persons (50% vs. 37%, respectively), their reports of arthralgia and of other clinical signs did not differ significantly: temperature >38.5°C (8% vs. 2%), enlarged lymph nodes (12% vs. 9%). No seropositive hunter reported having had an eschar.

This study provides data for Germany on the seroprevalence of Rickettsia spp. in persons highly exposed to ticks. Our results suggest that Rickettsia spp. are endemic to southern Germany and may cause autochthonous infections. Although most seropositive hunters exhibited reactivity to several rickettsial antigens, some had species-specific titers for R. helvetica. Six hunters exhibited specific reactivity to R. aeschlimannii. Serologic cross-reactions are frequently noted among spotted fever group rickettsiae, and 1 of the best indicators of species identity remains the geographic origin of the infection (7). Until now, R. aeschlimannii had not been detected in Germany or neighboring countries. We therefore suggest that the specific titers against R. aeschlimannii in our study population may be partly related to traveling or hunting abroad and that the observed seroprevalence for other rickettsial species is most likely caused by R. helvetica, or, alternatively, by R. monacensis, which was recently isolated from a tick in the English Garden in Munich (9). Cutoff titers for IgM and IgG were chosen to achieve a specificity >98%; sensitivity varied between different rickettsial antigens. However, if we assume a sensitivity of only 50% (with a prevalence of 9.1%), the positive predictive value of our test would still be 74%. In addition, a test with high specificity and low sensitivity underestimates the true seroprevalence; the proportion of seropositive hunters in our study group is likely higher.

Although hunters with positive immunofluorescence assay results reported having had symptoms compatible with rickettsioses more frequently than did seronegative hunters, these differences were not significant. A similar situation has been noted for persons who were tested for antibodies against Borrelia burgdorferi and human granulocytic anaplasmosis; the findings may reflect the mild and poorly defined clinical picture that is typical for each of these diseases (10).

To conclude, we report the presence of Rickettsia spp. antibodies in a high-risk group from Germany. Final proof that human rickettsiosis occurs in Germany, however, will require the isolation of the agent from patients.



We thank Malgorzata Lanowska, Mandy Mangler, and Christina Frank for their selfless assistance in recruiting the hunters.


Andreas JansenComments to Author , Bernard La Scola, Didier Raoult, Michael Lierz, Ole Wichmann, Klaus Stark, and Thomas Schneider

Author affiliations: Robert Koch Institute, Berlin, Germany (A. Jansen, O. Wichmann, K. Stark); Faculté de Médecine, Marseille, France (B. La Scola, D. Raoult); Free University of Berlin, Berlin (M. Lierz); Charité, Berlin (T. Schneider)



  1. Parola  P, Paddock  CD, Raoult  D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev. 2005;18:71956. DOIPubMedGoogle Scholar
  2. Burgdorfer  W, Aeschlimann  A, Peter  O, Hayes  SF, Philip  RN. Ixodes ricinus: vector of a hitherto undescribed spotted fever group agent in Switzerland. Acta Trop. 1979;36:35767.PubMedGoogle Scholar
  3. Beati  L, Péter  O, Burgdorfer  W, Aeschlimann  A, Raoult  D. Confirmation that Rickettsia helvetica sp. nov. is a distinct species of the spotted fever group of rickettsiae. Int J Syst Bacteriol. 1993;43:5216.PubMedGoogle Scholar
  4. Fournier  PE, Allombert  C, Supputamongkol  Y, Caruso  G, Brouqui  P, Raoult  D. Aneruptive fever associated with antibodies to Rickettsia helvetica in Europe and Thailand. J Clin Microbiol. 2004;42:8168. DOIPubMedGoogle Scholar
  5. Nilsson  K, Lindquist  O, Påhlson  C. Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet. 1999;354:116973. DOIPubMedGoogle Scholar
  6. Hartelt  K, Oehme  R, Frank  H, Brockmann  S, Hassler  D, Kimmig  P. Pathogens and symbionts in ticks: prevalence of Anaplasma phagocytophilum (Ehrlichia sp.), Wolbachia sp., Rickettsia sp., and Babesia sp. in southern Germany. Int J Med Microbiol. 2004;293:8692.PubMedGoogle Scholar
  7. La Scola  B, Raoult  D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol. 1997;35:271527.PubMedGoogle Scholar
  8. Brouqui  P, Bacellar  F, Baranton  G, Birtles  RJ, Bjoërsdorff  A, Blanco  JR, Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect. 2004;10:110832. DOIPubMedGoogle Scholar
  9. Simser  JA, Palmer  AT, Fingerle  V, Wilske  B, Kurtti  TJ, Munderloh  UG. Rickettsia monacensis sp. nov., a spotted fever group Rickettsia, from ticks (Ixodes ricinus) collected in a European city park. Appl Environ Microbiol. 2002;68:455966. DOIPubMedGoogle Scholar
  10. Fingerle  V, Goodman  JL, Johnson  RC, Kurtti  TJ, Munderloh  UG, Wilske  B. Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol. 1997;35:32447.PubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1412.080229

Related Links


Table of Contents – Volume 14, Number 12—December 2008

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Andreas Jansen, Department of Infectious Diseases Epidemiology, Robert Koch Institute, Seestrasse 10, 13353 Berlin, Germany;

Send To

10000 character(s) remaining.


Page created: July 22, 2010
Page updated: July 22, 2010
Page reviewed: July 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.